Vanguard MySuper
This product charges less than the median MySuper product, which costs $400 a year on a $50,000 balance.
Returns are what this product has already earned over the period shown. They are not a forecast and they do not indicate what it will earn next.
Fund and Product Details
| Offered by | Vanguard Super |
|---|---|
| Trustee | Vanguard Super Pty Ltd |
| Fund | Vanguard Super |
| Type of fund | Retail fund Run by a bank, insurer or investment company, which earns a profit from running it as well as paying returns to members. Anyone can generally join one. |
| Who can join | Anyone can join this fund |
| How your money is invested | Moved between investments as you get older, in 36 published stages |
| APRA annual performance test | Pass* An asterisk on a performance test result is APRA’s own footnote marker. APRA publishes the note that applies alongside the annual performance test results. |
| Member accounts | 44,870 |
| Total member assets | $2.7b |
Fees and returns by lifecycle stage
This is a lifecycle product, so it invests a member differently depending on their age and publishes a separate set of figures for each stage. That is why the fees and returns above are shown as a range rather than a single number. Each range runs from the lowest to the highest figure among the stages that reported one, and the table below lists every stage with the figures it reported. Stage names appear exactly as the fund published them.
- Growth assets
- 92.50%
- Total fees on $50,000
- 0.49%$245 a year
- Net return, 7 years
- Not yet reportable
- Net return, 10 years
- Not yet reportable
- Growth assets
- 55.00%
- Total fees on $50,000
- 0.49%$245 a year
- Net return, 7 years
- Not yet reportable
- Net return, 10 years
- Not yet reportable
These are the first and last stages in the order the fund published them. The lowest and highest figures in a range can belong to any stage.
All 36 published stages
| Stage | Growth assets | Total fees | Admin fees | Net return | Investment return | ||||
|---|---|---|---|---|---|---|---|---|---|
| 5 years | 7 years | 10 years | 5 years | 7 years | 10 years | ||||
| Lifecycle Age 47 and under | 92.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 48 | 90.63% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 49 | 88.75% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 50 | 86.88% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 51 | 85.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 52 | 83.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 53 | 82.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 54 | 80.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 55 | 79.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 56 | 77.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 57 | 75.63% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 58 | 73.75% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 59 | 71.88% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 60 | 70.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 61 | 68.13% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 62 | 66.25% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 63 | 64.38% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 64 | 62.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 65 | 62.13% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 66 | 61.75% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 67 | 61.38% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 68 | 61.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 69 | 60.62% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 70 | 60.17% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 71 | 59.72% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 72 | 59.20% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 73 | 58.75% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 74 | 58.30% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 75 | 57.85% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 76 | 57.33% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 77 | 56.88% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 78 | 56.50% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 79 | 56.13% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 80 | 55.75% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 81 | 55.38% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
| Lifecycle Age 82 and above | 55.00% | 0.49% | 0.29% | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable | Not yet reportable |
Fees and net returns are shown as a share of a $50,000 balance, which is the balance APRA reports them at. Investment returns are published as a rate, not against a balance. Every return is a yearly average over its period. A dash means the fund has not reported that figure, usually because the stage does not have enough history for the period. It does not mean a return of zero.
Figures on this page are published by APRA in its annual Comprehensive Product Performance Package. This page is general advice only, not personal advice. It does not take into account your objectives, financial situation or needs. Fees and returns are shown as a share of a $50,000 balance because that is the basis APRA reports them on, and your own balance, insurance cover and contributions will change what you actually pay and earn. Read the fund’s Product Disclosure Statement and Target Market Determination before making any decision. CompareThat is a comparison service and is not a superannuation fund or a financial adviser. No one has paid for this product to appear here or for the position it holds in our listings.
Important information
Find out moreShow less
Fees and returns shown are the figures published in APRA’s annual product performance publications, expressed as a percentage of a $50,000 account balance. They are updated when APRA republishes, not daily, and fees a fund charges may have changed since. Returns are what a product has already earned after fees and tax. Past performance is not an indicator of future performance. Before acting on any information shown here, you should confirm the fees, returns and product information with the fund.
We do not compare every MySuper product available in Australia, and this table does not compare every feature that may be relevant to you. Products are selected for relevance to the table and to the filters applied. They are not suggestions or recommendations, and the order they appear in is not a ranking of suitability. Changing the filters will surface further relevant products. See how we sort and rank products.
No product in this table is a sponsored placement, and no fund pays us for a click through from this table. A fund can pay for a sponsored placement, and any product in one is marked “Sponsored Placement” wherever it appears. Payment never decides which products we show, and it never changes the fees, returns or other figures, which come from APRA. See how we make money and our advertiser disclosure.
This information is general in nature. It does not take into account your objectives, financial situation or needs, and it is not a recommendation to apply for or hold any particular product. You should read the fund’s Product Disclosure Statement and Target Market Determination before deciding, and consider whether the product suits your age, your other super and your circumstances. CompareThat compares products. We do not arrange, approve or process applications.